Affiliation: Lund University
- Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson
Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden
Eur J Cancer 43:2109-16. 2007..0001) and with increasing age (p=0.0016). Anxiety associated with prostate cancer screening in general is low to moderate, even in men with elevated PSA, and severe anxiety affects a smaller group of susceptible men...
- The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trialSigrid Carlsson
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Bruna Straåket 11B, Goteborg, Sweden
Eur J Cancer 47:545-53. 2011..The aim of this study was to evaluate the treatment related morbidity following radical prostatectomy in men participating in the Göteborg randomised population-based prostate cancer screening trial...
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trialJonas Hugosson
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden
Lancet Oncol 11:725-32. 2010..One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate...
- The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund
Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
BJU Int 110:638-43. 2012..The main conclusion was that the absence of voiding symptoms is an independent risk factor for prostate cancer detection...
- Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort studySigrid Carlsson
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden
BMJ 348:g2296. 2014..To determine the relative risks of prostate cancer incidence, metastasis, and mortality associated with screening by serum prostate specific antigen (PSA) levels at age 60...
- Nationwide population-based study on 30-day mortality after radical prostatectomy in SwedenSigrid Carlsson
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Scand J Urol Nephrol 43:350-6. 2009..Radical prostatectomy (RP) is currently commonly performed, either within or outside large high-volume centres. The aim of this study was to assess the 30-day mortality rate after RP in Sweden...